During the past decade, Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 13 clinical trials were completed, i.e. on average, 185.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 7 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "PTC Therapeutics" with 2 trials sponsored, "Westat" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 5 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS" are "HIV Infections" (6 trials), "Genetic Diseases, Inborn" (2 trials), "Genetic Diseases, X-Linked" (2 trials), "HIV" (2 trials) and "Juvenile Idiopathic Arthritis" (2 trials). Many other conditions were trialed in "Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS" in a lesser frequency.

Most popular intervention types in "Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS" are "Drug" (14 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ataluren" (2 trials), "Risdiplam" (2 trials), "CP-690,550 (tofacitinib)" (1 trials) and "DTG dispersible tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS" are 10 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".